Clik here to view.
The unmet need for precision medicine in Lyme disease
Lyme disease cases and complications are rising, yet current treatment regimens are proving to be insufficient. Clarivate Senior Science Editor Shyama Ghosh and Managing Editor Stephen DuPraw...
View ArticleClik here to view.
Immuno-oncology breakthroughs: from precision medicine to modulating the...
The European Association for Cancer Research (EACR) explores the most exciting cancer research from Europe and globally. Clarivate Life Sciences Editor Joan Tur reviews the top three trends from their...
View ArticleClik here to view.
COVID-19 vaccines: Social media user sentiments and strategies to encourage...
Although the pandemic continues to influence lives around the world, recent advances in vaccine development and distribution offer hope for relief. However, there is still uncertainty and...
View ArticleClik here to view.
Best practices hospitals can adopt during vendor standardization: Q&A with...
In this interview, Lori Goucher, system clinical value analysis manager at Intermountain Healthcare, discusses best practices and success drivers in hospital vendor standardization. The first step in...
View ArticleClik here to view.
How to bring drugs to market in Singapore, the world’s most efficient...
This second blog in our series on health technology assessments (HTAs) in the Asia-Pacific (APAC) region examines the process by which HTAs are conducted in Singapore and what this means for market...
View ArticlePatient advocates speak out on partnering with life science companies
What does patient centricity mean from a patient’s point of view, and what kind of support do patient advocates need from life science companies? Three prominent patient advocates shared their...
View ArticleState review boards take on drug prices amid Congressional inaction
How are states tackling high drug prices and increasing affordability? Clarivate market access expert Stephanie Hoops discusses the emergence of affordability review boards. Done waiting for Congress...
View ArticleUnique insights to inform strategic portfolio strategy
Learn how Neuland Laboratories, an India- based API manufacturer leveraged a combination of Cortellis Generics Intelligence and Cortellis Competitive Intelligence for trusted information around target...
View ArticleAccelerating drug discovery at the Melbourne Biomedical Precinct
33% of Australia’s 2017-2018 drug discovery efforts occurred within the Melbourne Biomedical Precinct (the Precinct) and continues to grow. The Precinct consistently attracts 23% of National Health and...
View ArticleStreamline regulatory requirements monitoring and distribution
The regulatory intelligence team at a medium-sized pharmaceutical company was challenged to stay on top of on-going legislative changes across a variety of regions and disease areas, to support teams...
View Article